We are live on ! Find out more
KOC

Koss-Olinger Consulting Portfolio holdings

AUM $1.19B
1-Year Est. Return 15.91%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+15.91%
3 Year Est. Return
+50.95%
5 Year Est. Return
+57.89%
10 Year Est. Return
AUM
$674M
AUM Growth
+$86.7M
Cap. Flow
+$55.2M
Cap. Flow %
8.2%
Top 10 Hldgs %
62.2%
Holding
265
New
32
Increased
101
Reduced
58
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 5.55%
2 Consumer Discretionary 3.99%
3 Technology 2.95%
4 Communication Services 2.53%
5 Financials 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
26
Unity
U
$12.5B
$2.8M 0.42%
25,500
DIS icon
27
Walt Disney
DIS
$165B
$2.79M 0.41%
15,887
-446
-3% -$80.2K
XOM icon
28
ExxonMobil
XOM
$651B
$2.69M 0.4%
42,687
+1,912
+5% +$114K
VOO icon
29
Vanguard S&P 500 ETF
VOO
$968B
$2.66M 0.4%
6,769
+3,497
+107% +$1.34M
AAPL icon
30
Apple
AAPL
$4.89T
$2.66M 0.39%
19,416
-7,184
-27% -$931K
INTC icon
31
Intel
INTC
$466B
$2.48M 0.37%
44,197
+2,364
+6% +$139K
RVLV icon
32
Revolve Group
RVLV
$1.79B
$2.41M 0.36%
35,000
MOAT icon
33
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
$2.34M 0.35%
+31,625
New +$2.3M
CVS icon
34
CVS Health
CVS
$137B
$2.09M 0.31%
25,013
+728
+3% +$59.6K
CRSP icon
35
CRISPR Therapeutics
CRSP
$4.58B
$2.05M 0.3%
12,650
+1,441
+13% +$175K
MRK icon
36
Merck
MRK
$324B
$2.02M 0.3%
25,983
+555
+2% +$41.3K
ARCT icon
37
Arcturus Therapeutics
ARCT
$157M
$1.99M 0.3%
58,800
+38,800
+194% +$1.31M
IVE icon
38
iShares S&P 500 Value ETF
IVE
$48.9B
$1.99M 0.29%
13,460
-353
-3% -$52K
ARKG icon
39
ARK Genomic Revolution ETF
ARKG
$1.51B
$1.94M 0.29%
21,000
-390
-2% -$33.2K
BEAM icon
40
Beam Therapeutics
BEAM
$2.58B
$1.93M 0.29%
15,000
EDIT icon
41
Editas Medicine
EDIT
$399M
$1.82M 0.27%
32,100
QQQ icon
42
Invesco QQQ Trust
QQQ
$455B
$1.63M 0.24%
4,589
-4,290
-48% -$1.44M
VTI icon
43
Vanguard Total Stock Market ETF
VTI
$654B
$1.61M 0.24%
7,239
-497
-6% -$108K
NIO icon
44
NIO
NIO
$11.3B
$1.6M 0.24%
+30,019
New +$1.2M
CCL icon
45
Carnival Corporation Ltd
CCL
$36.1B
$1.58M 0.24%
60,143
KO icon
46
Coca-Cola
KO
$354B
$1.58M 0.24%
29,277
+2,381
+9% +$130K
JNJ icon
47
Johnson & Johnson
JNJ
$635B
$1.55M 0.23%
9,392
-682
-7% -$113K
VTIP icon
48
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.52M 0.23%
+29,041
New +$1.51M
SDY icon
49
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$1.47M 0.22%
12,025
-114
-0.9% -$14.1K
MSFT icon
50
Microsoft
MSFT
$2.84T
$1.47M 0.22%
5,413
-957
-15% -$243K

Similar funds

Koss-Olinger Consulting's Q2 2021 Portfolio in Review

As of Q2 2021, Koss-Olinger Consulting held 265 positions worth $674M, up 15% from $587M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Koss-Olinger Consulting deployed $55.2M of net new capital in Q2 2021, opening 32 new positions and adding to 101 existing holdings. Its largest new stake was Pacer Trendpilot US Bond ETF: 2,293,399 shares worth $63.5M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was State Street SPDR Portfolio Emerging Markets ETF, an estimated $31.6M trimmed.

  • Koss-Olinger Consulting's largest Q2 2021 buy was Pacer Trendpilot US Bond ETF: 2,293,399 shares worth $63.5M.
  • Koss-Olinger Consulting added most to Schwab US Large- Cap ETF in Q2 2021, an estimated $37.7M increase.
  • Koss-Olinger Consulting's biggest Q2 2021 reduction was State Street SPDR Portfolio Emerging Markets ETF, cutting an estimated $31.6M.
  • Koss-Olinger Consulting fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q2 2021, selling an estimated $35.6M.
  • Koss-Olinger Consulting's ten largest holdings make up 62% of its $674M portfolio in Q2 2021.
  • Koss-Olinger Consulting opened 32 new positions and closed 21 in Q2 2021.
  • Koss-Olinger Consulting's portfolio value rose 15% quarter-over-quarter to $674M.

Based on Koss-Olinger Consulting's 13F filing for Q2 2021, filed 11 Aug 2021.